Insider Transactions in Q4 2021 at Dexcom Inc (DXCM)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2021
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
250
-0.71%
|
$143,250
$573.91 P/Share
|
|
Dec 15
2021
|
Kevin R Sayer President CEO and Chairman |
SELL
Open market or private sale
|
Direct |
3,000
-0.26%
|
$1,608,000
$536.15 P/Share
|
|
Dec 15
2021
|
Barry J. Regan EVP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
1,671
+11.29%
|
-
|
|
Dec 15
2021
|
Sadie Stern EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,671
+11.04%
|
-
|
|
Dec 15
2021
|
Chad Patterson EVP Global Marketing |
BUY
Grant, award, or other acquisition
|
Direct |
2,925
+18.93%
|
-
|
|
Dec 15
2021
|
Paul R Flynn EVP Global Revenue |
BUY
Grant, award, or other acquisition
|
Direct |
2,925
+17.43%
|
-
|
|
Dec 15
2021
|
Jereme M Sylvain EVP, Chief Financal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,925
+16.12%
|
-
|
|
Dec 15
2021
|
Jacob Steven Leach EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,925
+3.89%
|
-
|
|
Dec 14
2021
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Bona fide gift
|
Direct |
5,459
-13.45%
|
-
|
|
Dec 13
2021
|
Barry J. Regan EVP Operations |
SELL
Open market or private sale
|
Direct |
1,214
-9.58%
|
$683,482
$563.93 P/Share
|
|
Dec 06
2021
|
Jereme M Sylvain EVP, Chief Financal Officer |
SELL
Open market or private sale
|
Direct |
600
-4.65%
|
$310,200
$517.59 P/Share
|
|
Dec 01
2021
|
Mark G Foletta Director |
SELL
Open market or private sale
|
Indirect |
500
-0.49%
|
$281,500
$563.37 P/Share
|
|
Nov 23
2021
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
250
-0.61%
|
$153,000
$612.26 P/Share
|
|
Nov 23
2021
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
1,195
-9.2%
|
$731,340
$612.26 P/Share
|
|
Nov 22
2021
|
Barry J. Regan EVP Operations |
SELL
Open market or private sale
|
Direct |
837
-6.2%
|
$534,006
$638.65 P/Share
|
|
Nov 22
2021
|
Sadie Stern EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
856
-6.18%
|
$546,128
$638.65 P/Share
|
|
Nov 15
2021
|
Kevin R Sayer President CEO and Chairman |
SELL
Open market or private sale
|
Direct |
3,000
-0.49%
|
$1,944,000
$648.5 P/Share
|
|
Nov 15
2021
|
Shelly Ramasamy Selvaraj SVP Chief Information Officer |
SELL
Bona fide gift
|
Direct |
250
-1.92%
|
-
|
|
Nov 12
2021
|
Kevin R Sayer President CEO and Chairman |
SELL
Bona fide gift
|
Direct |
3,000
-3.31%
|
-
|
|
Nov 09
2021
|
Jereme M Sylvain EVP, Chief Financal Officer |
SELL
Grant, award, or other acquisition
|
Direct |
634
-4.69%
|
$401,956
$634.12 P/Share
|
|
Nov 03
2021
|
Richard Alexander Collins Director |
SELL
Open market or private sale
|
Indirect |
1,500
-17.23%
|
$970,500
$647.05 P/Share
|
|
Nov 01
2021
|
Mark G Foletta Director |
SELL
Open market or private sale
|
Indirect |
500
-0.34%
|
$312,500
$625.76 P/Share
|
|
Oct 29
2021
|
Nicholas Augustinos Director |
SELL
Open market or private sale
|
Direct |
2,500
-73.14%
|
$1,500,000
$600.03 P/Share
|
|
Oct 22
2021
|
Steven Robert Pacelli EVP Managing Director Dexcom V |
SELL
Open market or private sale
|
Direct |
250
-0.61%
|
$142,500
$570.0 P/Share
|
|
Oct 15
2021
|
Kevin R Sayer President CEO and Chairman |
SELL
Open market or private sale
|
Direct |
6,000
-0.71%
|
$3,300,000
$550.39 P/Share
|
|
Oct 13
2021
|
Chad Patterson EVP Global Marketing |
SELL
Open market or private sale
|
Direct |
141
-1.45%
|
$76,845
$545.54 P/Share
|
|
Oct 01
2021
|
Mark G Foletta Director |
SELL
Open market or private sale
|
Indirect |
500
-0.51%
|
$271,500
$543.46 P/Share
|